Key facts
- It has raised $56.0M; the latest was Later Stage VC ($13.9M) in Aug 2025.
- Notable investors include CICC Capital, Frees Fund, Highlight Capital, Jinding Capital, Borchid Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Methuselah Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Methuselah Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Methuselah Medical Technology
Developer and provider of medical nutrition technologies intended to supply nutrition. The company partnered with a strategic partner in the United States to develop a series of medical nutrition products in line with the characteristics of the Chinese population and adhered to the concept of different nutrition for different groups of people, enabling clients with medical nutrition products.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shanghai, China
- Founded
- 2012
- Employees
- 68
- Website
- mn969.com/
- Ownership
- Privately Held (backing)
Methuselah Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Methuselah Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Methuselah Medical Technology in its N-PORT filings yet. We sweep new filings monthly.